Preliminary programme

Please, note that the Conference agenda may still undergo significant changes due to organizational reasons.

ADVANCES IN THROMBOTIC MICROANGIOPATHIES

Chairs: Paul Coppo (France), Nicola Ciavarella (Italy)

9:00-9:20

Challenges in the classification and nomenclature of different forms of microangiopathies
Marina Vivarelli (Italy)

9:20-9:40

Novel mechanism underlying pathogenesis of immune thrombotic thrombocytopenic purpura (aTTP)
Long Zheng (US)

9:40-10:00

Anti-VWF therapies in iTTP: now and then
Paul Coppo (France)

10:00-10:15

Discussion

KEYNOTE LECTURE

10:15-10:40

The loss of tolerance in patients who previously underwent ITI
Sébastien Lacroix-Desmazes (France)

10:40-11:10

Coffee break

NEW INDICATIONS FOR BISPECIFIC ANTIBODIES

Chairs: Caterina Casari (France), Cecile Denis (France)

11:10-11:30

Bispecific antibodies in acquired haemophilia A
Robert Klamroth (Germany)

11:30-11:50

Experimental and clinical rationale for the use of bispecific antibodies in von Willebrand disease
Caterina Casari (France)

11:50-12:00

Discussion

SATELLITE SYMPOSIUM

12:00-13:00

Sponsored by Sanofi Genzyme

13:00-14:30

Lunch

SATELLITE LECTURE

14:30-15:00

Sponsored by Biomarin

15:00-15:30

ORAL COMMUNICATIONS: LATEST ADVANCES PROPOSED BY THE INDUSTRY

15:30-16:30

E-POSTER SESSION

16:30-16:50

Coffee break

16:50-17:30

ROUND TABLE ON GENE THERAPY
Chairs: Flora Peyvandi (Italy), Mike Makris (UK)
Discussants: Declan Noone (Ireland), Brian O’Mahony (Ireland), Glenn Pierce (US)

17:30

Wrap up and closing remarks
Flora Peyvandi (Italy), Pier Mannuccio Mannucci (Italy)